DEF 14A

Company

Lantern Pharma Inc.

Filed

August 8, 2025

Period of Report

August 8, 2025

Accession Number

0001641172-25-022820

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →